Ads

 

Ads

 

Ads

 

World Top 100 Biotechnology Companies List by Market Cap as of August 2026

World Top 100 Biotechnology Companies List by Market Cap as of August 2026, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as of August 2026.

Metatag Title
World Top Biotechnology Companies in 2026
Metatag Abstract
World Largest Biotechnology Companies by Market Cap in 2026, World Top Biotechnology Companies by Market Cap in 2026.
  1. Hutchison China Meditech

    World Rank (Aug-2026)
    5,578
    Market Cap (Aug-2026)
    2.522 Billion USD
    World Rank (Jan-05-2024)
    4,263
    Market Cap (Jan-05-2024)
    3.110 Billion USD
    World Rank (Jul-30-2023)
    4,768
    Market Cap (Jul-30-2023)
    2.625 Billion USD
    World Rank (Dec-25-2022)
    4,511
    Market Cap (Dec-25-2022)
    2.635 Billion USD
    World Rank (Jan-07-2022)
    2,820
    Market Cap (Jan-07-2022)
    6.03 Billion USD
    Annual Revenue in USD
    356 Million USD
    Annual Net Income in USD
    -194 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Hutchison China Meditech is an innovative, commercial stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The headquarters is in Hong Kong.

  2. Viridian Therapeutics Inc.

    World Rank (Aug-2026)
    5,601
    Market Cap (Aug-2026)
    2.501 Billion USD
    World Rank (Jan-05-2024)
    7,887
    Market Cap (Jan-05-2024)
    1.157 Billion USD
    World Rank (Jul-30-2023)
    10,091
    Market Cap (Jul-30-2023)
    0.775 Billion USD
    World Rank (Dec-25-2022)
    7,533
    Market Cap (Dec-25-2022)
    1.200 Billion USD
    World Rank (Jan-07-2022)
    14,511
    Market Cap (Jan-07-2022)
    0.43 Billion USD
    Annual Revenue in USD
    71 Million USD
    Annual Operating Income in USD
    -363 Million USD
    Annual Net Income in USD
    -343 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
  3. BioCryst Pharmaceuticals

    World Rank (Aug-2026)
    5,615
    Market Cap (Aug-2026)
    2.489 Billion USD
    World Rank (Jan-05-2024)
    7,310
    Market Cap (Jan-05-2024)
    1.323 Billion USD
    World Rank (Jul-30-2023)
    7,021
    Market Cap (Jul-30-2023)
    1.451 Billion USD
    World Rank (Dec-25-2022)
    5,228
    Market Cap (Dec-25-2022)
    2.135 Billion USD
    World Rank (Jan-07-2022)
    6,134
    Market Cap (Jan-07-2022)
    2.08 Billion USD
    Annual Revenue in USD
    875 Million USD
    Annual Operating Income in USD
    341 Million USD
    Annual Net Income in USD
    264 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    BioCryst Pharmaceuticals is a Biotechnology company designs and develops small molecule medicines for rare diseases like hereditary angioedema (HAE) and fibrodysplasia ossificans progressive (FOP). The company annual revenue is 49 million USD and 140 employees as on 2019. The headquarters is in USA.
  4. Bavarian Nordic A/S

    World Rank (Aug-2026)
    5,630
    Market Cap (Aug-2026)
    2.477 Billion USD
    World Rank (Jan-05-2024)
    5,688
    Market Cap (Jan-05-2024)
    1.998 Billion USD
    World Rank (Jul-30-2023)
    6,479
    Market Cap (Jul-30-2023)
    1.648 Billion USD
    World Rank (Dec-25-2022)
    5,163
    Market Cap (Dec-25-2022)
    2.170 Billion USD
    World Rank (Jan-07-2022)
    5,303
    Market Cap (Jan-07-2022)
    2.64 Billion USD
    Annual Revenue in USD
    255 Million USD
    Annual Net Income in USD
    -62 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Bavarian Nordic is a fully integrated vaccines company focused on the development, manufacturing and commercialization of life saving vaccines. The company annual revenue is 1,852.3 million DKK, annual operating income is 379.5 million DKK and total assets are 8,759 DKK as on 2020. The headquarters is in Denmark.
  5. Nektar Therapeutics

    World Rank (Aug-2026)
    5,639
    Market Cap (Aug-2026)
    2.467 Billion USD
    World Rank (Jan-05-2024)
    21,027
    Market Cap (Jan-05-2024)
    0.108 Billion USD
    World Rank (Jul-30-2023)
    21,502
    Market Cap (Jul-30-2023)
    0.103 Billion USD
    World Rank (Dec-25-2022)
    13,797
    Market Cap (Dec-25-2022)
    0.404 Billion USD
    World Rank (Jan-07-2022)
    5,673
    Market Cap (Jan-07-2022)
    2.34 Billion USD
    Annual Revenue in USD
    55 Million USD
    Annual Operating Income in USD
    -140 Million USD
    Annual Net Income in USD
    -164 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Nektar Therapeutics is a research based development stage Biopharmaceutical company. It R&D pipeline of new investigational drugs includes treatments for cancer and auto immune disease and leverage Nektar's proprietary and proven chemistry platform in the discovery and design of new drug candidates. The headquarters is in USA.
  6. Pharvaris N.V.

    World Rank (Aug-2026)
    5,661
    Market Cap (Aug-2026)
    2.448 Billion USD
    World Rank (Jan-05-2024)
    7,301
    Market Cap (Jan-05-2024)
    1.326 Billion USD
    World Rank (Jul-30-2023)
    11,900
    Market Cap (Jul-30-2023)
    0.573 Billion USD
    World Rank (Dec-25-2022)
    15,021
    Market Cap (Dec-25-2022)
    0.335 Billion USD
    World Rank (Jan-07-2022)
    11,928
    Market Cap (Jan-07-2022)
    0.64 Billion USD
    Headquarters Country
    Company Profile
    Pharvaris is a biotechnology sector company related clinical-stage company focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. Headquarters is in Netherlands.
  7. BGI Genomics

    World Rank (Aug-2026)
    5,708
    Market Cap (Aug-2026)
    2.410 Billion USD
    World Rank (Jan-05-2024)
    4,702
    Market Cap (Jan-05-2024)
    2.701 Billion USD
    World Rank (Jul-30-2023)
    3,941
    Market Cap (Jul-30-2023)
    3.459 Billion USD
    World Rank (Dec-25-2022)
    3,971
    Market Cap (Dec-25-2022)
    3.121 Billion USD
    World Rank (Jan-07-2022)
    2,873
    Market Cap (Jan-07-2022)
    5.90 Billion USD
    Annual Revenue in USD
    985 Million USD
    Annual Net Income in USD
    213 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    BGI Genomics is the leading provider of genomic sequencing services and proteomic services company. The company annual revenue is 1.5 billion USD and 3,585 employees as on 2020. The headquarters is in China.

  8. Amylyx Pharmaceuticals Inc.

    World Rank (Aug-2026)
    5,709
    Market Cap (Aug-2026)
    2.410 Billion USD
    World Rank (Jan-05-2024)
    8,008
    Market Cap (Jan-05-2024)
    1.123 Billion USD
    World Rank (Jul-30-2023)
    6,840
    Market Cap (Jul-30-2023)
    1.514 Billion USD
    World Rank (Dec-25-2022)
    4,858
    Market Cap (Dec-25-2022)
    2.356 Billion USD
    World Rank (Jan-07-2022)
    8,733
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -153 Million USD
    Annual Net Income in USD
    -145 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Amylyx Pharmaceuticals Inc is a pharmaceutical company that is dedicated to the development of potential therapies for neurodegenerative diseases. The headquarters is in United States.
  9. Urogen Pharma

    World Rank (Aug-2026)
    5,781
    Market Cap (Aug-2026)
    2.357 Billion USD
    World Rank (Jan-05-2024)
    13,467
    Market Cap (Jan-05-2024)
    0.435 Billion USD
    World Rank (Jul-30-2023)
    12,378
    Market Cap (Jul-30-2023)
    0.530 Billion USD
    World Rank (Dec-25-2022)
    18,356
    Market Cap (Dec-25-2022)
    0.188 Billion USD
    World Rank (Jan-07-2022)
    18,931
    Market Cap (Jan-07-2022)
    0.20 Billion USD
    Annual Revenue in USD
    110 Million USD
    Annual Operating Income in USD
    -125 Million USD
    Annual Net Income in USD
    -153 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    UroGen Pharma is a Biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases. The company annual revenue is 3.5 million USD and 156 employees as on 2020. The headquarters is in USA.
  10. Vera Therapeutics Inc.

    World Rank (Aug-2026)
    5,905
    Market Cap (Aug-2026)
    2.279 Billion USD
    World Rank (Jan-05-2024)
    10,674
    Market Cap (Jan-05-2024)
    0.689 Billion USD
    World Rank (Jul-30-2023)
    10,207
    Market Cap (Jul-30-2023)
    0.761 Billion USD
    World Rank (Dec-25-2022)
    11,799
    Market Cap (Dec-25-2022)
    0.550 Billion USD
    World Rank (Jan-07-2022)
    14,196
    Market Cap (Jan-07-2022)
    0.45 Billion USD
    Annual Operating Income in USD
    -315 Million USD
    Annual Net Income in USD
    -300 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country

Share

Ads